---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-034814"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2025-04-24T23:59:59+00:00"
generated_at: "2026-05-23T07:06:05.656561+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# SS Innovations approved for Nasdaq listing; trading begins April 25 under SSII

## Summary
- Common stock approved for listing on Nasdaq Capital Market; trading begins April 25, 2025 under symbol SSII.
- Installed 80 SSi Mantra systems in 75 hospitals; performed 3,500+ surgeries including 195 robotic cardiac surgeries with zero device-related mortality.
- Received CDSCO approval for telesurgery/tele-proctoring; performed 16 telesurgeries including world's first robotic cardiac telesurgery up to 1,200 miles.
- FY2024 revenue $20.6M (+251% YoY); gross margin 40.9% (up from 12.3% in 2023).
- Pursuing EU CE Mark (late 2025) and U.S. FDA approval (early 2026) for SSi Mantra system.

## SEC filing metadata
- accession: 0001213900-25-034814
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2025-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390025034814/0001213900-25-034814-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390025034814/ea0239340-8k_ssinnov.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-034814
- JSON: https://secwatch.observer/filing/0001213900-25-034814.json
- Plain text: https://secwatch.observer/filing/0001213900-25-034814.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.